Real-Time Analyzers Develops Rapid COVID-19 Saliva Test

Real-Time Analyzers , Inc., (RTA) developer of chemical and biological agent analyzers for the U.S. military, today announced that the company has developed a simple-to-use saliva-based COVID-19 test kit.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Thursday, October 8, 2020
Information
Tags: 
Medical Supplies, Health, FDA, Medical devices, Infectious diseases, Clinical trials, Biotechnology, Medicine, COVID-19 testing, Coronavirus disease, Saliva, Real-time analyzer, Branches of biology, Articles
Geotags: 
United States, Connecticut
⚠ generated by AI ↴
Organisation: 
REAL-TIME ANALYZERS
Summary
Key Points: 
  • Real-Time Analyzers , Inc., (RTA) developer of chemical and biological agent analyzers for the U.S. military, today announced that the company has developed a simple-to-use saliva-based COVID-19 test kit.
  • The COVID-19 Saliva Antigen Test kit includes a straw-like tube to collect and transfer saliva to a sample vial, to which buffer is added to inactivate the virus in the saliva, and a pipette to transfer a few drops to a pregnancy-style test strip.
  • The absence, to this point, of a rapid and accurate self-test has been the predominant challenge in controlling the spread of COVID-19, said Dr. Stuart Farquharson, President, Real-Time Analyzers.
  • Ideal for the workplace, schools, sport teams and events, RTAs COVID-19 Saliva Antigen Test kit is currently entering its second stage of FDA testing.


Real-Time Analyzers, Inc., (RTA) developer of chemical and biological agent analyzers for the U.S. military, today announced that the company has developed a simple-to-use saliva-based COVID-19 test kit. The COVID-19 Saliva Antigen Test kit includes a straw-like tube to collect and transfer saliva to a sample vial, to which buffer is added to inactivate the virus in the saliva, and a pipette to transfer a few drops to a pregnancy-style test strip. Saliva flows across the strip producing a test result in 15-20 minutes, with one visible line on the strip indicating the user is not infected and two visible lines indicating the user is infected.

“The absence, to this point, of a rapid and accurate self-test has been the predominant challenge in controlling the spread of COVID-19,” said Dr. Stuart Farquharson, President, Real-Time Analyzers. “With our new saliva-based test, users can quickly and easily determine if they are infected with COVID-19, helping to prevent further spread and enabling those who test positive to make an informed decision regarding personal contact and more quickly begin the process of contact tracing. For those not infected, the test can provide a welcome measure of personal relief.”

Ideal for the workplace, schools, sport teams and events, RTA’s COVID-19 Saliva Antigen Test kit is currently entering its second stage of FDA testing. Approval is expected in November. Once approved, the kit will be available to the general public at a cost of $50 for a single kit and as low as $10 per kit for volume orders. In an effort to encourage more people to get tested, RTA will provide refunds to those who test positive.

About Real-Time Analyzers:

Real-Time Analyzers, Inc. (RTA) is a privately owned company founded in 2001. RTA develops spectroscopy-based products for chemical, biochemical, and pathogen analysis. The core employees have over 100 years combined experience in building instruments and developing analyses. RTA has delivered numerous analyzers to the US Army, Air Force, Navy and Marine Corps, for use in the Middle East. Additional RTA analyzers have been delivered to the Australian, Canadian and United Kingdom governments, and NASA. For more information, please visit www.RTA.biz.

Copyright: 
Copyright Business Wire 2020